Microfluidics News Microfluidics News

  • Microfluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting
    by iga.willmann on 4th May 2020 at 1:47 pm

      Researchers in the Department of Pharmacy at the Ludwig Maximilian University of Munich are using chips from Dolomite Microfluidics to reliably and consistently produce monodisperse particles for targeted delivery of small interfering RNA (siRNA) therapeutics. This microfluidic encapsulation technology is ideal for gene silencing applications in cancer immunology and inflammatory diseases, where siRNA can potentially... The post Microfluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting appeared first on Dolomite Microfluidics.

  • FACS sorting droplets: Expression assays in double emulsions using the Dolomite µEncapsulator
    by iga.willmann on 8th April 2020 at 3:20 pm

      Single cell analysis coupled with FACS enables our customers to increase throughput, lower costs and improve the quality of their assays. Single cell analysis is key in identifying population heterogeneity, highlighting crucial sub-populations along with discovering novel characteristics of individual cells.  The Dolomite µEncapsulator system facilitates single cell encapsulation into droplets ready for fluorescence-activated... The post FACS sorting droplets: Expression assays in double emulsions using the Dolomite µEncapsulator appeared first on Dolomite Microfluidics.

  • Dolomite Microfluidics and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests
    by iga.willmann on 2nd April 2020 at 10:33 am

      As the COVID-19 pandemic progresses in countries around the globe, there is an urgent need for rapid and reliable point-of-need detection testing. Dolomite Microfluidics and Mologic are working together to accelerate development and launch these tests.   UK-based company, Mologic is a leading developer of rapid response diagnostic tests for diseases such as malaria... The post Dolomite Microfluidics and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests appeared first on Dolomite Microfluidics.

  • A COVID-19 update to all our customers and members of the scientific community
    by Aaron Sims on 18th March 2020 at 2:35 pm

      This is a message to all our customers, partners and the scientific community about the recent events concerning the outbreak of the novel coronavirus (COVID-19). These are challenging time for everyone and some of our customers will be greatly influenced by this pandemic in one way or another. We at Dolomite Microfluidics would like... The post A COVID-19 update to all our customers and members of the scientific community appeared first on Dolomite Microfluidics.

  • Dolomite Microfluidics shares its expertise in core-shell microparticle production
    by Gina Mikalauskaite on 5th March 2020 at 10:46 am

      Dolomite Microfluidics, a world leader in microfluidics innovation, has released its latest application note, Microfluidic Production of 20 to 50 μm Core-Shell PLGA Beads, enabling scientists around the globe to benefit from the company’s in-depth knowledge of the encapsulation of hydrophilic materials, such as active pharmaceutical ingredients (APIs). This recent addition to the company’s... The post Dolomite Microfluidics shares its expertise in core-shell microparticle production appeared first on Dolomite Microfluidics.

University of Toronto partners National Research Council to create a national research hub for microfluidics.

Shrinking entire medical labs onto chips with the help of nanotechnology